CORRECTION to: Clinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (Archives of Neuropysychiatry, 60, 23)

dc.contributor.authorTerzi, Murat
dc.contributor.authorHelvacı, Elif Merve
dc.contributor.authorŞen, Sedat
dc.contributor.authorBoz, Cavit
dc.contributor.authorÇilingir, Vedat
dc.contributor.authorAkçali, Aylin
dc.contributor.authorBeckmann, Yeşim
dc.contributor.authorTerzi, Yüksel
dc.date.accessioned2023-07-27T08:13:23Z
dc.date.available2023-07-27T08:13:23Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Teknolojisi Bölümü, Farmasötik Teknoloji Ana Bilim Dalı
dc.description.abstractThe name of the author Gökçe Sözer was mistakenly written as Gökçe Sezer. The correct name and institution are as follows.
dc.identifier.citationTerzi, M., Helvacı, E. M., Şen, S., Boz, C., Çilingir, V., Akçali, A. ... Terzi, Y. (2023). CORRECTION to: Clinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (Archives of Neuropysychiatry, 60, 23). Archives of Neuropsychiatry, 60(2), 190-190. https://dx.doi.org/10.29399/npa.28499
dc.identifier.doi10.29399/npa.28499
dc.identifier.endpage190
dc.identifier.issn1300-0667
dc.identifier.issue2
dc.identifier.pmid37287556
dc.identifier.scopus2-s2.0-85164255146
dc.identifier.scopusqualityQ3
dc.identifier.startpage190
dc.identifier.urihttps://dx.doi.org/10.29399/npa.28499
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11265
dc.identifier.volume60
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorSözer, Gökçe
dc.language.isoen
dc.publisherTurkish Neuropsychiatric Society
dc.relation.ispartofArchives of Neuropsychiatryen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFingolimod Treatment
dc.subjectMultiple Sclerosis Patients
dc.subjectClinical and Demographic Characteristics
dc.titleCORRECTION to: Clinical and demographic characteristics and two-year efficacy and safety data of 508 multiple sclerosis patients with fingolimod treatment (Archives of Neuropysychiatry, 60, 23)
dc.typeOther

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Sozer-Gokce-2023.pdf
Boyut:
61.21 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: